Skip to content

BiomX Inc.

PHGE

CIK 0001739174 · Biological Products, (No Diagnostic Substances) · NYSE

  • Chardan Healthcare Acquisition Corp. (until 2019-10-23)
← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$42M
−104.2% YoY Q1 May 2026
EPS Diluted (TTM)
$14.13
−61.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$32.32M
Q1 May 2026
Cash
$1.17M
Q1 May 2026
Total Debt
$18.61M
Q1 May 2026
Shares Outstanding
10.15M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings